Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Pietras

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Seminars in Oncology|June 4, 2004
Increasing tumor uptake of anticancer drugs with imatinibKristian Pietras
Frontiers in Oncology|June 1, 2016
Editorial: Novel Targets and Targeting Technologies to Modulate Tumor MicroenvironmentJai Prakash, Kristian Pietras
Biochemical and Biophysical Research Communications|June 23, 2018
PDGF family function and prognostic value in tumor biologyMichael Bartoschek, Kristian Pietras
Upsala Journal of Medical Sciences|March 22, 2012
Of mice and men: a comparative study of cancer-associated fibroblasts in mammary carcinomaPernilla Roswall, Kristian Pietras
Cancer Science|June 24, 2020
Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicineRyu Kanzaki, Kristian Pietras
Cell Cycle (Georgetown, Tex.)|April 28, 2009
On the origin of cancer-associated fibroblastsCharlotte Anderberg, Kristian Pietras
Experimental Cell Research|March 10, 2010
Hallmarks of cancer: interactions with the tumor stromaKristian Pietras, Arne Ostman
Experimental Cell Research|September 23, 2014
Introduction to tumor-stroma interactionsArne Ostman, Kristian Pietras
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 2004
A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancerKristian Pietras, Douglas Hanahan
Upsala Journal of Medical Sciences|April 4, 2024
Cellular plasticity in the breast cancer ecosystemKristian Pietras, Jonas Sjölund
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Seminars in Oncology|June 4, 2004
Increasing tumor uptake of anticancer drugs with imatinibKristian Pietras
Frontiers in Oncology|June 1, 2016
Editorial: Novel Targets and Targeting Technologies to Modulate Tumor MicroenvironmentJai Prakash, Kristian Pietras
Biochemical and Biophysical Research Communications|June 23, 2018
PDGF family function and prognostic value in tumor biologyMichael Bartoschek, Kristian Pietras
Upsala Journal of Medical Sciences|March 22, 2012
Of mice and men: a comparative study of cancer-associated fibroblasts in mammary carcinomaPernilla Roswall, Kristian Pietras
Cancer Science|June 24, 2020
Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicineRyu Kanzaki, Kristian Pietras
Cell Cycle (Georgetown, Tex.)|April 28, 2009
On the origin of cancer-associated fibroblastsCharlotte Anderberg, Kristian Pietras
Experimental Cell Research|March 10, 2010
Hallmarks of cancer: interactions with the tumor stromaKristian Pietras, Arne Ostman
Experimental Cell Research|September 23, 2014
Introduction to tumor-stroma interactionsArne Ostman, Kristian Pietras
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 2004
A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancerKristian Pietras, Douglas Hanahan
Upsala Journal of Medical Sciences|April 4, 2024
Cellular plasticity in the breast cancer ecosystemKristian Pietras, Jonas Sjölund
Pageof 11